Navigation Links
Spaulding Clinical Announces New Joint Partnership for Global Studies with Eurofins Optimed Clinical Research

WEST BEND, Wis., Aug. 8, 2011 /PRNewswire/ -- Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint partnership agreement.  This partnership leverages the strengths of both companies and facilitates collaboration on integrated clinical services to engage pharmaceutical clients who demand a global footprint.

"The culture of excellence and research facilities designed to execute high-quality studies was very impressive to our team.  We felt immediately comfortable with the Optimed clinical team and witnessed their efficient execution of studies," states Daniel Selness, General Manager and Senior Vice President of Operations.  "We were very impressed that Spaulding achieved ISO certification, which is not common among US clinical research facilities.  Their innovative systems approach with Electronic Data Capture is something that we have been looking to implement, so the partnership will allow us to consider how to collaborate more closely as these systems are put in place," states Yves Donazzolo, MD, CEO and President of Optimed.

Eurofins Optimed and Spaulding Clinical offer a full range of global services to the Pharmaceutical industry and Biotechnology companies from study design through study execution/conduct, data management, statistical analysis, and medical writing.  Both companies excel in TQT, first-in-human, multiple rising dose, bioavailability/bioequivalence, drug interaction, food effect studies and Proof-Of-Concept studies in patients.

Eurofins Optimed (, founded in 1990, is located in France and provides Phase I- IV clinical research services.  Eurofins Optimed operates 100 beds in two clinical pharmacology units, in Grenoble and Lyon. Studies in healthy volunteers are conducted in the units while patient trials are performed in various European centers. As a member of the Eurofins Group, the company offers a customized range of global drug development services.

Spaulding Clinical Research, LLC ( provides Clinical Pharmacology, Cardiac Core Lab clinical research services and is a medical device manufacturer. Spaulding Clinical operates a 105-bed clinical pharmacology unit with 96-beds of Mortara telemetry in West Bend, Wisconsin.  The facility is paperless with a phase I Electronic Data Capture system and bi-directional interfaces to safety lab, bedside devices and telemetry.  As a Phase I-IV Core Laboratory provider,  Spaulding offers the complete suite of equipment provisioning and electrocardiogram over-reading services, including the proprietary Spaulding iQ Electrocardiograph.

SOURCE Spaulding Clinical Research, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spaulding Clinical Honored at BizTech Conference
2. Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
3. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
4. Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea
5. SI-BONE Announces Global Clinical Strategy for Minimally Invasive iFuse Sacroiliac Joint Fusion
6. Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels
7. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
8. Biomatrica and USAMRIID Sign a CRADA for the Development of New Technologies Applicable for Ambient Stabilization of Clinical and Biological Samples
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Australian Biotech Ceridia Pty Ltd Completes Successful Human Clinical Trial
11. Quest Diagnostics to Unveil Extensions to its Womens Health and Personalized Medicine Test Offerings at the 2011 AACC Annual Meeting and Clinical Lab Expo
Post Your Comments:
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):